Core Laboratories N V

AMERIPRISE FINANCIAL INC

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/22/2023

Shares

902,625

Value ($000)

19,903

Weight

0.0%

2013 Q4 - 2023 Q1 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/22/2023	19,903	0.0%	902,625	3/31/2023
2022 Q4	2/14/2023	6,836	0.0%	337,281	12/31/2022
2022 Q3	11/14/2022	4,496	0.0%	333,464	9/30/2022
2022 Q2	8/15/2022	7,187	0.0%	362,742	6/30/2022
2022 Q1	5/16/2022	17,743	0.0%	560,930	3/31/2022
2021 Q4	2/14/2022	11,648	0.0%	522,041	12/31/2021
2021 Q3	11/15/2021	14,277	0.0%	514,523	9/30/2021
2021 Q2	8/16/2021	27,668	0.0%	710,232	6/30/2021
2021 Q1	5/17/2021	20,363	0.0%	707,599	3/31/2021
2020 Q4	2/12/2021	15,888	0.0%	599,383	12/31/2020
2020 Q3	11/16/2020	7,803	0.0%	511,321	9/30/2020
2020 Q2	8/14/2020	9,546	0.0%	469,742	6/30/2020
2020 Q1	5/15/2020	3,491	0.0%	337,669	3/31/2020
2019 Q4	2/14/2020	23,883	0.0%	634,096	12/31/2019
2014 Q1	5/14/2014	14,292	0.0%	72,030	3/31/2014
2013 Q4	2/14/2014	18,223	0.0%	95,438	12/31/2013